MoneyWorks4Me

Sanjivani Paranteral - Quaterly Results

18 Oct 2023 Evaluate
The Turnover for the quarter ended September 2023 of Rs. 140.03 millions increase by 68.08% from Rs. 83.31 millions.The company almost doubled its revenue to Rs. 17.06 millions  from Rs. 7.65 millions in the quarter ended September 2023.Operating profit for the quarter ended September 2023 rose to 22.64 millions as compared to 12.99 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 140.03 83.31 68.08 265.84 182.48 45.68 354.92 306.13 15.94
Other Income 1.50 1.66 -9.64 2.10 2.83 -25.80 5.54 2.43 127.98
PBIDT 22.64 12.99 74.29 43.35 35.73 21.33 61.90 59.69 3.70
Interest 0.46 0.72 -36.11 0.89 1.46 -39.04 3.59 2.13 68.54
PBDT 22.18 12.27 80.77 42.46 34.27 23.90 58.31 57.56 1.30
Depreciation 2.32 2.17 6.91 4.61 4.34 6.22 8.88 8.77 1.25
PBT 19.86 10.10 96.63 37.85 29.93 26.46 49.43 48.79 1.31
TAX 2.80 2.45 14.29 5.30 4.31 22.97 4.33 0.32 1253.13
Deferred Tax 0.00 -0.05 0.00 0.00 -0.69 -100.00 -6.10 0.32 -2006.25
PAT 17.06 7.65 123.01 32.55 25.62 27.05 45.10 48.47 -6.95
Equity 99.98 99.98 0.00 99.98 99.98 0.00 99.98 99.98 0.00
PBIDTM(%) 16.17 15.59 3.69 16.31 19.58 -16.72 17.44 19.50 -10.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..